Department of Obstetrics and Gynaecology

Induction of labor in women with prior cesarean section: outcomes in a selected low-risk population (2026) Kehl S, Weiss C, Düster H, Bader S, Faschingbauer F, Schneider M, Beckmann M, et al. Journal article Effect of postoperative hormonal therapy on pain following endometriosis surgery: a retrospective cohort study (2026) Blum S, Hofbeck L, Sipulina N, Au K, Lotz L, Giacomozzi M, Fasching P, et al. Journal article Sex-specific differences in patients with differentiated thyroid carcinoma and their possible impact on survival (2026) Heinrich M, Blickle E, Jedamzik T, Kohnle P, Kerscher A, Verburg FA, Buck AK, Michalski K Journal article Immune cells employ intermittent integrin-mediated traction forces for 3D migration (2026) Czerwinski T, Bischof L, Böhringer D, Kara S, Strissel P, Strick R, Huhn N, et al. Journal article Physiologically-Based Pharmacokinetics of Ribociclib Drug–Drug Interactions and Organ Impairment Pharmacokinetics in Early Breast Cancer (2026) Ji Y, Huth F, Wang C, Schiller H, Combes FP, Crown J, Fasching P, et al. Journal article Stereotactic Vacuum-Assisted Biopsy in Photon-Counting Dedicated Spiral Breast CT: A Proof of Concept Stereotaktische Vakuumbiopsie in der photonenzählenden dedizierten Spiral-Brust-CT: ein Machbarkeitsnachweis (2026) Schulz-Wendtland R, Wacker T, Heinemann D, Steiding C, Kolditz D, Althoff F, Wenkel E, et al. Journal article Diagnosis and Therapy of EndometriosisGuideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/045, April 2025) Diagnostik und Therapie der Endometriose. Leitlinie der DGGG, OEGGG und SGGG (S2k-Level, AWMF-Registernummer 015/045, April 2025) (2026) Burghaus S, Schäfer SD, Bär KJ, Bartley J, Beckmann M, Behrens A, Beyer K, et al. Journal article Clinical management of common toxicities with inhibitors targeting the PI3K/AKT/mTOR pathway in breast cancer (2026) Jhaveri KL, Iyengar NM, Turner NC, Rugo HS, O'Shaughnessy J, Barrios CH, Curigliano G, et al. Journal article, Review article Standardized patient coaching improves therapy persistence in patients with hormone receptor–positive, HER2–negative advanced/metastatic breast cancer treated with abemaciclib (2026) Welslau M, Fasching P, Semmler-Lins N, Mueller L, Belleville E, Rieger L, Uhrig S, et al. Journal article Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer (2026) Billaud A, Figlioli G, Mooser C, Casamassima I, Azzoni V, Srivatsa J, Colombo M, et al. Journal article